Literature DB >> 8022794

The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake.

L Castillo1, M Sánchez, T E Chapman, A Ajami, J F Burke, V R Young.   

Abstract

We hypothesized recently that arginine homeostasis is achieved in humans largely by modulating the rate of arginine degradation. We have tested this hypothesis further by measuring in vivo the whole body rate of conversion of arginine to ornithine and ornithine oxidation in six healthy young adults. Subjects received for 6 days an L-amino acid-based diet supplying an arginine-rich or arginine-free intake and on day 7, following an overnight fast, an 8-h tracer protocol (first 3 h, fast state; next 5 h, fed state) was conducted; L-[guanidino-15N2; 5,5-2H]arginine and L-[5-13C]ornithine were given as primed, constant intravenous tracers; measurements of the abundances of various isotopologs of arginine, ornithine, and citrulline in plasma were made, and from these the various kinetic parameters of the metabolism of these amino acids were derived. Arginine and ornithine fluxes were significantly (P < 0.001) reduced in the fed state with arginine-free feeding. The rates of conversion (mumol.kg-1.h-1; mean +/- SD) of plasma arginine to ornithine for arginine-rich were 12.9 +/- 2.6 and 24.7 +/- 4.8 for fast and fed states. These values were 11.1 +/- 3.5 and 9.6 +/- 1.2 (P > 0.05 and P < 0.001), respectively, with an arginine-free diet. [13C]Ornithine oxidation was reduced (P < 0.001) by 46% during the fed state when the arginine-free diet was given. The findings strengthen our hypothesis that homeostasis of arginine metabolism in the human host depends importantly upon a regulation in the rate of arginine degradation with, perhaps, little involvement in the de novo net rate of arginine synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022794      PMCID: PMC44208          DOI: 10.1073/pnas.91.14.6393

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  Regulation of enzymes of urea and arginine synthesis.

Authors:  S M Morris
Journal:  Annu Rev Nutr       Date:  1992       Impact factor: 11.848

2.  Net renal arginine flux in rats is not affected by dietary arginine or dietary protein intake.

Authors:  S N Dhanakoti; J T Brosnan; M E Brosnan; G R Herzberg
Journal:  J Nutr       Date:  1992-05       Impact factor: 4.798

3.  Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.

Authors:  W W Grody; C Argyle; R M Kern; G J Dizikes; E B Spector; A D Strickland; D Klein; S D Cederbaum
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Determination of the isotope enrichment of one or a mixture of two stable labelled tracers of the same compound using the complete isotopomer distribution of an ion fragment; theory and application to in vivo human tracer studies.

Authors:  J A Vogt; T E Chapman; D A Wagner; V R Young; J F Burke
Journal:  Biol Mass Spectrom       Date:  1993-10

5.  Dietary arginine uptake by the splanchnic region in adult humans.

Authors:  L Castillo; T E Chapman; Y M Yu; A Ajami; J F Burke; V R Young
Journal:  Am J Physiol       Date:  1993-10

6.  Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets.

Authors:  L Castillo; T E Chapman; M Sanchez; Y M Yu; J F Burke; A M Ajami; J Vogt; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

7.  Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes.

Authors:  V Pelletier; L Marks; D A Wagner; R A Hoerr; V R Young
Journal:  Am J Clin Nutr       Date:  1991-08       Impact factor: 7.045

8.  Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.

Authors:  S W Brusilow; J Finkelstien
Journal:  Metabolism       Date:  1993-10       Impact factor: 8.694

9.  Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man.

Authors:  L Castillo; T C deRojas; T E Chapman; J Vogt; J F Burke; S R Tannenbaum; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state.

Authors:  J T Clarke; D M Bier
Journal:  Metabolism       Date:  1982-10       Impact factor: 8.694

View more
  12 in total

1.  Arginine metabolic endotypes in pulmonary arterial hypertension.

Authors:  Christina C Kao; Samuel H Wedes; Jean W Hsu; Kurt M Bohren; Suzy A A Comhair; Farook Jahoor; Serpil C Erzurum
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

2.  Hepatic zonation of the catabolism of arginine and ornithine in the perfused rat liver.

Authors:  D O'sullivan; J T Brosnan; M E Brosnan
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling.

Authors:  L Castillo; L Beaumier; A M Ajami; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Pharmacokinetics of intravenous and oral L-arginine in normal volunteers.

Authors:  O Tangphao; M Grossmann; S Chalon; B B Hoffman; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

5.  Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginine-free diets.

Authors:  Juan C Marini; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  J Nutr       Date:  2010-06-23       Impact factor: 4.798

6.  Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients.

Authors:  T Lau; W Owen; Y M Yu; N Noviski; J Lyons; D Zurakowski; R Tsay; A Ajami; V R Young; L Castillo
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Arginase I expression and activity in human mononuclear cells after injury.

Authors:  J B Ochoa; A C Bernard; W E O'Brien; M M Griffen; M E Maley; A K Rockich; B J Tsuei; B R Boulanger; P A Kearney; S M Morris
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 8.  Arginine de novo and nitric oxide production in disease states.

Authors:  Yvette C Luiking; Gabriella A M Ten Have; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

9.  In vivo renal arginine release is impaired throughout development of chronic kidney disease.

Authors:  Gin-Fu Chen; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

10.  Adaptation to a long term (4 weeks) arginine- and precursor (glutamate, proline and aspartate)-free diet.

Authors:  John F Tharakan; Yong M Yu; David Zurakowski; Rachel M Roth; Vernon R Young; Leticia Castillo
Journal:  Clin Nutr       Date:  2008-06-30       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.